NasdaqGS - Nasdaq Real Time Price USD
Pacira BioSciences, Inc. (PCRX)
26.62
+0.47
+(1.80%)
As of 3:18:10 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 7 | 7 |
| Avg. Estimate | 0.69 | 0.64 | 2.84 | 3.43 |
| Low Estimate | 0.47 | 0.42 | 2.09 | 3.05 |
| High Estimate | 0.81 | 0.74 | 3.39 | 4.29 |
| Year Ago EPS | 0.89 | 0.79 | 3.2 | 2.84 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 7 | 7 |
| Avg. Estimate | 184.25M | 184.15M | 744.11M | 833.42M |
| Low Estimate | 180.22M | 180.4M | 730.54M | 804.5M |
| High Estimate | 189.97M | 192.51M | 774.92M | 920.45M |
| Year Ago Sales | 178.02M | 168.57M | 700.97M | 744.11M |
| Sales Growth (year/est) | 3.50% | 9.24% | 6.16% | 12.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | 0.7 | 0.7 | 0.83 | 0.6 |
| EPS Actual | 0.89 | 0.79 | 0.91 | 0.62 |
| Difference | 0.19 | 0.09 | 0.08 | 0.02 |
| Surprise % | 27.30% | 12.07% | 9.60% | 3.83% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0.69 | 0.64 | 2.84 | 3.43 |
| 7 Days Ago | 0.75 | 0.68 | 2.9 | 3.64 |
| 30 Days Ago | 0.75 | 0.68 | 2.9 | 3.64 |
| 60 Days Ago | 0.73 | 0.68 | 2.83 | 3.62 |
| 90 Days Ago | 0.92 | 0.88 | 3.44 | 3.77 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 2 | 1 |
| Up Last 30 Days | 1 | 2 | 3 | 2 |
| Down Last 7 Days | -- | -- | -- | 1 |
| Down Last 30 Days | 4 | 4 | 3 | 4 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| PCRX | -22.77% | -18.56% | -11.38% | 20.81% |
| S&P 500 | 13.32% | 2.69% | 7.77% | 13.75% |
Upgrades & Downgrades
| Maintains | Needham: Buy to Buy | 5/9/2025 |
| Reiterates | Needham: Buy to Buy | 4/8/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 4/8/2025 |
| Maintains | Barclays: Overweight to Overweight | 2/28/2025 |
| Maintains | Needham: Buy to Buy | 2/28/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 2/28/2025 |
Related Tickers
COLL Collegium Pharmaceutical, Inc.
30.07
+0.80%
CPIX Cumberland Pharmaceuticals Inc.
5.17
-5.11%
ELAN Elanco Animal Health Incorporated
12.99
-1.78%
SCYX SCYNEXIS, Inc.
0.7911
-4.92%
SUPN Supernus Pharmaceuticals, Inc.
33.30
+0.74%
ETON Eton Pharmaceuticals, Inc.
19.59
+0.10%
IRWD Ironwood Pharmaceuticals, Inc.
0.6538
+6.85%
4506.T Sumitomo Pharma Co., Ltd.
833.00
-0.72%
ORGO Organogenesis Holdings Inc.
3.2500
+0.62%
RDY Dr. Reddy's Laboratories Limited
14.44
-0.17%